Literature DB >> 21355829

Contrast echocardiography in critical care: echoes of the future? A review of the role of microsphere contrast echocardiography.

David G Platts1, John F Fraser.   

Abstract

Echocardiography is an important diagnostic modality in the critical care setting. It is a safe, non-invasive bedside investigation that provides important cardiac structural, functional and haemodynamic information. However, in up to 25% of scans, the images are non-diagnostic, which can have a significant impact on patient diagnosis and management. Contrast echocardiography, using contrast microspheres coupled with contrast-specific ultrasound imaging modalities, overcomes many of the limitations that cause suboptimal echocardiograms in the critical care environment. These microspheres are haemodynamically inert and have the same intravascular rheology as red blood cells. By using the differential oscillating properties of myocardium and microspheres, contrast echocardiography can enhance the blood pool-myocardial interface, thus improving endocardial definition. Consequently, this technique can be used to improve the accuracy, feasibility and reproducibility of transthoracic echocardiography. The technique is well accepted and indicated for improving the image quality in suboptimal scans, and for the assessment of global and regional left ventricular (LV) function and LV ejection fraction. It also has a significant role to play in enhancing LV morphology (for conditions such as apical hypertrophic cardiomyopathy, pseudoaneurysm and non-compaction), assessing intracardiac masses and evaluating LV thrombus. Contrast echocardiography is of benefit in various clinical settings, particularly the critical care setting. Here it can salvage a non-diagnostic transthoracic echocardiogram, thus avoiding an alternative, more invasive investigation, while remaining a truly bedside, non-invasive investigative procedure. Future applications for contrast echocardiography could include use as a perfusion modality, enhancement of three-dimensional echocardiography, and targeted delivery of gene therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21355829

Source DB:  PubMed          Journal:  Crit Care Resusc        ISSN: 1441-2772            Impact factor:   2.159


  9 in total

1.  Impact of Contrast Echocardiography on Assessment of Ventricular Function and Clinical Diagnosis in Routine Clinical Echocardiography: Korean Multicenter Study.

Authors:  Doo-Youp Kim; Jung-Hyun Choi; Geu-Ru Hong; Se-Joong Rim; Jang-Young Kim; Sang-Chol Lee; Il-Suk Sohn; Wook-Jin Chung; Hye-Sun Seo; Se-Jung Yoon; Kyoung-Im Cho; Si-Wan Choi; Kyung-Jin Lee
Journal:  J Cardiovasc Ultrasound       Date:  2017-03-27

2.  Real-time monitoring of radiofrequency ablation and postablation assessment: accuracy of contrast-enhanced US in experimental rat liver model.

Authors:  Hanping Wu; Luke R Wilkins; Nicholas P Ziats; John R Haaga; Agata A Exner
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

3.  Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents.

Authors:  Hanping Wu; Nicolas G Rognin; Tianyi M Krupka; Luis Solorio; Hiroki Yoshiara; Gilles Guenette; Christopher Sanders; Naohisa Kamiyama; Agata A Exner
Journal:  Ultrasound Med Biol       Date:  2013-08-09       Impact factor: 2.998

4.  The effect of lipid monolayer in-plane rigidity on in vivo microbubble circulation persistence.

Authors:  Sumit Garg; Alex A Thomas; Mark A Borden
Journal:  Biomaterials       Date:  2013-06-17       Impact factor: 12.479

5.  Microsphere contrast echocardiography in the critical care complex.

Authors:  David G Platts; John F Fraser
Journal:  Crit Care       Date:  2011-04-06       Impact factor: 9.097

6.  Ultrasound-triggered phase transition sensitive magnetic fluorescent nanodroplets as a multimodal imaging contrast agent in rat and mouse model.

Authors:  Xin Cheng; Huan Li; Yunchao Chen; Binhua Luo; Xuhan Liu; Wei Liu; Haibo Xu; Xiangliang Yang
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  Quantification of perflutren microsphere contrast destruction during transit through an ex vivo extracorporeal membrane oxygenation circuit.

Authors:  David G Platts; Charles McDonald; Kiran Shekar; Darryl J Burstow; Daniel Mullany; Marc Ziegenfuss; Sara Diab; John F Fraser
Journal:  Intensive Care Med Exp       Date:  2016-03-11

8.  Left Ventricular Thrombi: Insights from Cardiac Magnetic Resonance Imaging.

Authors:  Narumol Chaosuwannakit; Pattarapong Makarawate
Journal:  Tomography       Date:  2021-05-12

Review 9.  Bedside myocardial perfusion assessment with contrast echocardiography.

Authors:  Sam Orde; Anthony McLean
Journal:  Crit Care       Date:  2016-03-15       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.